Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
36.60    0.10 (0.27%)
Bid:
36.50
Ask:
36.70
Spread: 0.20 (0.548%)
Market Cap: £26.87m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

Interim Management Statement

22 Jan 2014 07:00

RNS Number : 2240Y
Carclo plc
22 January 2014
Β 

22 January 2014

Β 

Carclo plc

("Carclo" or "the group")

Β 

Interim Management Statement

Β 

Β 

The board announces that the group's operating businesses, as expected, are enjoying stronger trading in the second half of the financial year but that lower than previously expected sales at Conductive Inkjet Technology ("CIT") will reduce the forecast profitability of CIT and hence of the group in the second half.

Β 

At CIT, sales of coated film in the second half are set to be ahead of the first half sales number, but below the board's previously disclosed estimated range. This is due to a slower than anticipated ramp up in production on the programs which are using XSenseβ„’ touch sensors. CIT's partner, Atmel Corporation ("Atmel"), recently announced its first production rollout for the HP Omni 10β„’ from its Colorado manufacturing site and Atmel continues to supply XSenseβ„’ for this program. Further programs are expected to progressively come on stream through the first half of 2014, benefitting from the superior capabilities of XSenseβ„’ (including narrow bezel capability) versus competitive offerings.

Β 

The market for XSenseβ„’ and other metal mesh solutions is growing rapidly as adoption begins to gain traction at the expense of ITO touch sensor solutions in this $5 billion market. At the same time we have seen competition in the market increase for all touch solutions, which is causing pricing pressure; while we expect developments in the touch sensor market to become clearer during 2014, this is likely to reduce coated film revenues and margins versus our previous estimates. The product capabilities of XSenseβ„’ are strong and we remain confident that it can gain a significant market share in this rapidly growing market.

Β 

The group's Technical Plastics, LED Technologies and Precision Engineering businesses are all performing in line with the board's expectations.

Β 

Technical Plastics has been awarded several new programs during the year and further significant program awards are anticipated within the next few months as this business enters a growth phase.

Β 

Within the LED Technologies Division we have secured new supercar lighting programs and anticipate further awards early in the next financial year which will drive significant growth in this specialist design and manufacturing business. Sales within the division's LED Optics are also growing well.

Β 

Precision Engineering continues to perform well and has maintained its prior year performance.

Β 

Progress at Carclo Diagnostic Solutions is as anticipated and we are on track to deliver working product prior to our year end for the previously disclosed trial project for an Acute Kidney Injury marker with EKF Diagnostics Systems plc.

Β 

The group's balance sheet is strong and its funding remains secure. The board looks forward to sales and profits progression across the group in the coming financial year.

Β 

Β 

- ENDS -

Β 

Β 

Enquiries:

Carclo plc

01924 268040

Chris Malley, Chief Executive

Robert Brooksbank, Finance Director

Weber Shandwick Financial

020 7067 0700

Nick Oborne / Stephanie Badjonat

Β 

Β 

Notes to editors

Β 

Carclo plc is a technology group. It is a public company whose shares are quoted on the London Stock Exchange.

Β 

Carclo's strategy has been to develop new technologies and products to drive future growth. Its investment in CIT has led to the introduction of a new material for use in Capacitive Touch Screens. Further investment has been made in Carclo Diagnostic Solutions, where a novel Point-of-Care hardware platform has been developed.

Β 

Approximately three fifths of revenues are currently derived from the supply of fine tolerance, injection moulded plastic components, which are used in medical, optical and electronics products. This business, Carclo Technical Plastics, operates internationally in a fast growing and dynamic market underpinned by rapid technological development.

Β 

Approximately two fifths of revenues are derived from the supply of specialised precision LED based systems to the premium automotive industry, as well as key control systems for the aerospace industry.

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSPGUPCGUPCUCP
Date   Source Headline
29th Apr 20264:59 pmRNSDirector Dealing – Late Notification
27th Apr 20267:00 amRNSHolding(s) in Company
23rd Apr 202610:34 amRNSHolding(s) in Company
23rd Apr 20267:00 amRNSTrading Update
24th Dec 202510:10 amRNSDirector/PDMR Shareholding
24th Dec 202510:10 amRNSDirector/PDMR Shareholding
25th Nov 20257:00 amRNSDirector/PDMR Shareholding
21st Nov 20257:00 amRNSHalf-year Financial Report
17th Nov 20257:00 amRNSNotice of Half Year Results
30th Sep 20256:20 pmRNSDirector/PDMR Shareholding
30th Sep 20256:14 pmRNSDirector/PDMR Shareholding
26th Sep 202512:30 pmRNSResult of AGM
26th Sep 20257:00 amRNSTrading Update
19th Sep 20255:58 pmRNSDirector/PDMR Shareholding
17th Sep 20257:00 amRNSChange of Auditor
11th Sep 20258:41 amRNSDirector/PDMR Shareholding
1st Sep 20257:30 amRNSRestoration - Carclo PLC
29th Aug 202511:55 amRNSNotice of AGM
29th Aug 20257:00 amRNSFull Year 2025 audited results
28th Aug 20257:00 amRNSNotice of Results and Investor Presentation
1st Aug 20257:30 amRNSSuspension - Carclo PLC
17th Jul 20254:42 pmRNSHolding(s) in Company
15th Jul 20257:00 amRNSContract renewal strengthens revenue visibility
10th Jul 20257:00 amRNSTrading Statement & Delay in 2025 Audited Results
2nd May 202511:33 amRNSHolding(s) in Company
30th Apr 20257:00 amRNSTrading Statement
28th Apr 20255:06 pmRNSHolding(s) in Company
24th Apr 20254:02 pmRNSRefinancing Arrangements, Pension Scheme Valuation
3rd Apr 20257:00 amRNSHolding(s) in Company
6th Mar 202510:43 amRNSHolding(s) in Company
18th Feb 20255:10 pmRNSHolding(s) in Company
13th Feb 20257:00 amRNSCFO Appointment
19th Dec 20243:49 pmRNSHolding(s) in Company
5th Dec 20247:00 amRNSInterim Report and Accounts 30 September 2024
12th Nov 202411:11 amRNSNotice of Interim Results & Investor Presentation
10th Sep 20249:33 amRNSHolding(s) in Company
5th Sep 20241:30 pmRNSResult of AGM
5th Sep 20247:00 amRNSTrading Update
16th Aug 202412:32 pmRNSHolding(s) in Company
5th Aug 202412:11 pmRNSHolding(s) in Company
31st Jul 202410:00 amRNS2024 Annual Report & Accounts and Notice of AGM
30th Jul 20243:21 pmRNSHolding(s) in Company
24th Jul 20242:49 pmRNSHolding(s) in Company
24th Jul 202412:57 pmRNSHolding(s) in Company
23rd Jul 20243:48 pmRNSHolding(s) in Company
23rd Jul 20241:08 pmRNSDirector/PDMR Shareholding
18th Jul 20247:00 amRNSFinal Results
17th Jul 20241:07 pmRNSHolding(s) in Company
16th Jul 20247:00 amRNSNotice of Results
8th Jul 20248:51 amRNSBank Facilities Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.